
Please try another search
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
Name | Age | Since | Title |
---|---|---|---|
Rahul Deshpande | - | - | Independent Nominee Director |
Kamlesh Shende | 69 | 2022 | Independent Director |
Padmakar Shrinivas Joshi | - | 2017 | Independent Director |
Ashok Bhatia | 70 | 2025 | Independent Director |
Gautam Rathindranath Saigal | 60 | 2024 | Non Executive & Non-Independent Director |
Niraj Pukhraj Dhadiwal | 58 | 2013 | Director of Business Development & Executive Director |
Anwar Siraj Daud | - | 2002 | Executive Chairman & MD |
Zulfiquar Murtaza Kamal | 64 | 2012 | Director of Finance & Executive Director |
Chandrashekhar Mainde | - | 2024 | CEO & Executive Director |
Prakash Pralhadrao Sapkal | 57 | 2013 | Head of ODS Business, Formulations of Domestic, ROW & Emerging Markets & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review